Mcf Advisors LLC 180 Life Sciences Corp. Transaction History

Mcf Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.81 - $2.53 $405 - $1,265	-500 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$2.53 - $3.9 $1,265 - $1,950	500 New	500 $1,000
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $1,635 - $3,190	-500 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$6.7 - $11.98 $16,750 - $29,950	-2,500 Reduced 83.33%	500 $5,000
Q1 2021 May 13, 2021	BUY	$2.51 - $6.96 $7,529 - $20,880	3,000 New	3,000 $20,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $141M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.